
NutraWomen Wednesday: Dr. Sabine Hazen, CEO of ProgenaBiome and Ventura Clinical Trials
For many, the gut microbiome is a relatively new term, but for Dr. Sabine Hazan, it’s been her focus for the last 25 years.

For many, the gut microbiome is a relatively new term, but for Dr. Sabine Hazan, it’s been her focus for the last 25 years.

A US Senate bill to specifically allow the use of CBD and other hemp derivatives in dietary supplements and foods has been introduced with bipartisan sponsorship. The bill also enjoys broad support within the industry.

Progress Biotech has received EU approval for the use of its high docosahexaenoic acid (DHA) algal oil in infant formula in a move that meets demand for sustainable vegan-based ingredients along with DHA’s known health benefits.

UK researchers have discovered a new bacterial species living in the gut that they say plays a key role in nitrogen availability - the process that makes available amino acids and proteins for the host.

MGC Pharma is working on introducing its product that has shown to speed up recovery in COVID-19 patients, as a natural health or ayurvedic product in several Asian countries, including India, Malaysia, Myanmar, and Thailand.

Swisse is ramping up new product development for its revamped beauty range as part of its focus into the ‘beauty in and out’ market in Australia and worldwide.

The use of a new type of highly porous microparticle and an encapsulation technology simultaneously has shown to increase the loading capacity of capsules for lactoferrin by more than 30 times, a group of researchers has found.

The Growth Asia Interactive Broadcast Series returns for 2021 to build on the huge success of its inaugural edition, where more than 3,200 industry delegates registered to hear expert insights from a raft of big-name brands, leading academics, policy...